# Megafine Pharma (P) Limited – FDA Inspection, Jan 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/5d607a40-9c0f-4492-9ad3-5f8e69123f40
Source feed: FDA_Inspections

> FDA inspection 1195646 of Megafine Pharma (P) Limited, January 24, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195646
- Company Name: Megafine Pharma (P) Limited
- Inspection Date: 2023-01-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1122874 - 2020-03-06](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/d31b8c30-3b1a-4524-8262-69f74885e8e4)
- [FDA Inspection 1054711 - 2018-05-12](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/ad44a079-acf0-43f8-84fb-ef3cf6fef858)
- [FDA Inspection 929021 - 2015-05-15](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/d0300afa-481e-4cf8-8dda-04e5a7d2cfc7)
- FDA Inspection 730085 - 2011-06-02

## Related Officers

- [Dipesh K. Shah](https://www.keypedia.com/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)
- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)

Company: https://www.keypedia.com/companies/megafine-pharma-p-limited/da2f1945-a6c8-4238-ad26-92b889339f04

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
